Label: TADALAFIL tablet, coated

5.2 Worsening Pulmonary Vascular Occlusive Disease
1.3 Erectile Dysfunction and Benign Prostatic Hyperplasia
12.3 Pharmacokinetics
Adverse effects

Physical features of yellow Cialis include smooth coating and visible markings.
Patients should avoid alcohol and grapefruit products while taking yellow Cialis.
The yellow color of Cialis pills signifies it's a PDE5 inhibitor.
The yellow Cialis pill is designed for quick absorption in the bloodstream.
Before use, check the packaging for authenticity of the yellow Cialis.
Side effects like dizziness may occur after taking yellow Cialis.
The yellow Cialis pill is known for its consistency in quality.
Cialis's active ingredient, tadalafil, is responsible for its effects.
Always follow dosing guidelines to prevent potential health risks.
The yellow Cialis pill enhances sexual performance by improving blood flow.
Education about yellow Cialis helps patients use it effectively.
Medical consultation is essential when considering yellow Cialis treatment.

5.2 Worsening Pulmonary Vascular Occlusive Disease

Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg. There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years. Animal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. 14 CLINICAL STUDIES 14.1 Tadalafil Tablets for Use as Needed for EDThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials cialis plus priligy of up to 24-weeks duration, involving over 4000 patients. Tadalafil tablets, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).Tadalafil tablets were studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration.

The Bottom Line

Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, tadalafil tablets were taken as needed, at doses ranging from 2.5 mg to 20 mg, up to once per day. Patients were free to choose the time interval between dose administration and the time of sexual attempts. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of tadalafil tablets on erectile function. The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). In dogs, an increased incidence of disseminated arteritis was observed in 1-month and 6-month studies at unbound tadalafil exposure of 1-month to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. In a 12-month dog study, no disseminated arteritis was observed, but 2 dogs exhibited marked decreases in white blood cells (neutrophils) and moderate decreases in platelets with inflammatory signs at unbound tadalafil exposures of approximately 14- to 18-fold the human exposure at the MRHD of 20 mg.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	5mg	30 + 4 Pills	53.56€ 51.01€
Cialis Original	20mg	8 Pills	61.70€ 58.76€
Cialis Soft Tabs	20mg	120 + 6 Pills	248.64€ 236.80€
Cialis Generic	20mg	20 Pills	54.72€ 52.11€
Cialis Super Active	20mg	120 + 16 Pills	382.15€ 363.95€
Cialis Generic	5mg	120 + 6 Pills	132.92€ 126.59€
Cialis Generic	5mg	90 + 6 Pills	115.91€ 110.39€
Cialis Professional	20mg	30 Pills	104.57€ 99.59€
Cialis Original	20mg	22 + 2 Pills	129.20€ 123.05€
Cialis Generic	40mg	360 + 10 Pills	477.87€ 455.11€
Cialis Generic	60mg	270 + 10 Pills	443.96€ 422.82€
Cialis Original	20mg	4 Pills	41.99€ 39.99€

1.3 Erectile Dysfunction and Benign Prostatic Hyperplasia

In beagle dogs given tadalafil daily for 3 months to 12 months, there was treatment-related non-reversible degeneration and atrophy of the seminiferous tubular epithelium in the testes in 20% to 100% of the dogs that resulted in a decrease in spermatogenesis in 40% to 75% of the dogs at doses of ≥10 mg/kg/day. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg.There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years.13.2 Animal Toxicology and/or PharmacologyAnimal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs. In mice and rats, lymphoid necrosis and hemorrhage were seen in the spleen, thymus, and mesenteric lymph nodes at unbound tadalafil exposure of 2- to 33-fold above the human exposure (AUCs) at the MRHD of 20 mg. In dogs, an increased incidence of disseminated arteritis was observed in 1-month and 6-month studies at unbound tadalafil exposure of 1-month to 54-fold above the human exposure (AUC) at the MRHD of 20 mg. In a 12-month dog study, no disseminated arteritis was observed, but 2 dogs exhibited marked decreases in white blood cells (neutrophils) and moderate decreases in platelets with inflammatory signs at unbound tadalafil exposures of approximately 14- to 18-fold the human exposure at the MRHD of 20 mg.

Patient resources

The abnormal blood-cell findings were reversible within 2 weeks after stopping treatment. Carcinogenesis - Tadalafil was not carcinogenic to rats or mice when administered daily for 2 years at doses up to 400 mg/kg/day. Systemic drug exposures, as measured by AUC of unbound tadalafil, were approximately 10-fold for mice, and 14- and 26-fold for male and female rats, respectively, the exposures in human males given Maximum Recommended Human Dose (MRHD) of 20 mg. Mutagenesis - Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. Impairment of Fertility - There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. Mutagenesis - Tadalafil was not mutagenic in the in vitro bacterial Ames assays or the forward mutation test in mouse lymphoma cells. Impairment of Fertility - There were no effects on fertility, reproductive performance or reproductive organ morphology in male or female rats given oral doses of tadalafil up to 400 mg/kg/day, a dose producing AUCs for unbound tadalafil of 14-fold for males or 26-fold for females the exposures observed in human males given the MRHD of 20 mg. Systemic exposure (based on AUC) at no-observed-adverse-effect-level (NOAEL) (10 mg/kg/day) for unbound tadalafil was similar to that expected in humans at the MRHD of 20 mg. There were no treatment-related testicular findings in rats or mice treated with doses up to 400 mg/kg/day for 2 years. Animal studies showed vascular inflammation in tadalafil-treated mice, rats, and dogs.

Yellow Cialis pills can be part of a comprehensive ED treatment plan.
Discuss potential risks and benefits with your doctor before use.
The yellow color aids in quick recognition in a medication regimen.
Limit alcohol intake when taking yellow Cialis for optimal results.
Cialis (yellow pills) should not be shared with others.
The medication acts by increasing blood flow to improve erections.
Cialis's effects can last up to 36 hours, offering flexibility.
Always verify the pill's authenticity before use to avoid counterfeit.
Side effects are usually mild but require attention and medical advice.
The yellow Cialis pill is often recommended for its long duration.
Men with certain health conditions should avoid yellow Cialis.
Cialis, including the yellow formulation, is considered safe when used correctly.

14 CLINICAL STUDIES 14.1 Tadalafil Tablets for Use as Needed for EDThe efficacy and safety of tadalafil in the treatment of erectile dysfunction has been evaluated in 22 clinical trials cialis plus priligy of up to 24-weeks duration, involving over 4000 patients. Tadalafil tablets, when taken as needed up to once per day, was shown to be effective in improving erectile function in men with erectile dysfunction (ED).Tadalafil tablets were studied in the general ED population in 7 randomized, multicenter, double-blinded, placebo-controlled, parallel-arm design, primary efficacy and safety studies of 12-weeks duration. Two of these studies were conducted in the United States and 5 were conducted in centers outside the US. Additional efficacy and safety studies were performed in ED patients with diabetes mellitus and in patients who developed ED status post bilateral nerve-sparing radical prostatectomy.In these 7 trials, tadalafil tablets were taken as needed, at doses ranging from 2.5 mg to 20 mg, up to once per day.

The yellow Cialis pill is often marketed with medical claims about ED treatment.
Online ordering of yellow Cialis should be done cautiously to avoid scams.
Yellow Cialis is used by men seeking a reliable solution for ED.
The pill's color helps distinguish it from other ED medications like Viagra.
Dosage adjustments for yellow Cialis depend on individual health factors.
The yellow Cialis pill can be taken on an empty stomach for quicker results.
The safety profile of yellow Cialis has been established through clinical trials.
Cialis, including the yellow dosage form, is prescribed worldwide.
Regular monitoring by a healthcare provider enhances safe use of yellow Cialis.
The yellow Cialis pill is an effective, long-lasting option for ED.
Potential interactions with other medications should be managed under medical advice.
The yellow Cialis pill is a widely trusted medication for ED management.

Patients were free to choose the time interval between dose administration and the time of sexual attempts. Food and alcohol intake were not restricted.Several assessment tools were used to evaluate the effect of tadalafil tablets on erectile function.

12.3 Pharmacokinetics

The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study. SEP Question 2 asks, “Were you able to insert your penis into the partner’s vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials - The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease.

What Are the Side Effects of Cialis and Tadalafil?

Most (>90%) patients reported ED of cialis vidalista 60mg at least 1-year duration. Study A was conducted primarily in academic centers. Study B was conducted primarily in community-based urology practices. In each of these 2 trials, tadalafil tablets 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Table 11). The treatment effect of tadalafil tablets did not diminish over time.Table 11: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in the Two Primary US TrialsResults in General ED Population in Trials Outside the US - The 5 primary efficacy and safety studies conducted in the general ED population outside the US included 1112 patients, with a mean age of 59 years (range 21 to 82 years). The 3 primary outcome measures were the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) and Questions 2 and 3 from Sexual Encounter Profile (SEP). The IIEF is a 4-week recall questionnaire that was administered at the end of a treatment-free baseline period and subsequently at follow-up visits after randomization. The IIEF EF domain has a 30-point total score, where higher scores reflect better erectile function. SEP is a diary in which patients recorded each sexual attempt made throughout the study. SEP Question 2 asks, “Were you able to insert your penis into the partner’s vagina?” SEP Question 3 asks, “Did your erection last long enough for you to have successful intercourse?” The overall percentage of successful attempts to insert the penis into the vagina (SEP2) and to maintain the erection for successful intercourse (SEP3) is derived for each patient.Results in ED Population in US Trials - The 2 primary US efficacy and safety trials included a total of 402 men with erectile dysfunction, with a mean age of 59 years (range 27 to 87 years). The population was 78% White, 14% Black, 7% Hispanic, and 1% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease.

Yellow Cialis pills are often taken 30 minutes prior to intimacy for best results.
Regular use of yellow Cialis can improve erectile function over time.
The yellow pill's profile includes a 36-hour window of effectiveness.
Cialis (yellow pill) may cause minor side effects in some users.
Safe use of yellow Cialis requires a medical consultation.
Some yellow Cialis pills are designed for daily low-dose use.
The yellow Cialis pill's vibrant color helps prevent mix-ups with other pills.
Cialis’s proprietary formula is designed for sustained blood flow support.
The yellow color is part of Cialis’s branding and quality assurance.
Yellow Cialis is not suitable for everyone and requires medical screening.
Proper storage of yellow Cialis maintains its efficacy and safety.
Use yellow Cialis responsibly, following prescribed doses and instructions.

Adverse effects

The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration. In these 5 trials, tadalafil tablets 5 mg, 10 mg, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 12, 13 and 14). The treatment effect of tadalafil tablets did not diminish over time.Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the USaTreatment duration in Study F was 6 monthsTable 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 (“Were you able to insert your penis into the partner’s vagina?”) in the General ED Population in Five Pivotal Trials Outside the USaTreatment duration in Study F was 6 monthsTable 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 (“Did your erection last long enough for you to have successful intercourse?”) in the General ED Population in Five Pivotal Trials Outside the USaTreatment duration in Study F was 6 monthsIn addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil tablets, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, tadalafil tablets showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus - Tadalafil tablets were shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil tablets in ED patients with type 1 or type 2 diabetes (N=216).

More common

In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with DiabetesEfficacy Results in ED Patients following Radical Prostatectomy - Tadalafil tablets were shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 16).Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical ProstatectomyResults in Studies to Determine the Optimal Use of Tadalafil Tablets- Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined. The population was 76% White, 1% Black, 3% Hispanic, and 20% of other ethnicities, and included patients with ED of various severities, etiologies (organic, psychogenic, mixed), and with multiple co-morbid conditions, including diabetes mellitus, hypertension, and other cardiovascular disease. Most (90%) patients reported ED of at least 1-year duration. In these 5 trials, tadalafil tablets 5 mg, 10 mg, and 20 mg showed clinically meaningful and statistically significant improvements in all 3 primary efficacy variables (see Tables 12, 13 and 14). The treatment effect of tadalafil tablets did not diminish over time.Table 12: Mean Endpoint and Change from Baseline for the EF Domain of the IIEF in the General ED Population in Five Primary Trials Outside the USaTreatment duration in Study F was 6 monthsTable 13: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 2 (“Were you able to insert your penis into the partner’s vagina?”) in the General ED Population in Five Pivotal Trials Outside the USaTreatment duration in Study F was 6 monthsTable 14: Mean Post-Baseline Success Rate and Change from Baseline for SEP Question 3 (“Did your erection last long enough for you to have successful intercourse?”) in the General ED Population in Five Pivotal Trials Outside the USaTreatment duration in Study F was 6 monthsIn addition, there were improvements in EF domain scores, success rates based upon SEP Questions 2 and 3, and patient-reported improvement in erections across patients with ED of all degrees of disease severity while taking tadalafil tablets, compared to patients on placebo.Therefore, in all 7 primary efficacy and safety studies, tadalafil tablets showed statistically significant improvement in patients’ ability to achieve an erection sufficient for vaginal penetration and to maintain the erection long enough for successful intercourse, as measured by the IIEF questionnaire and by SEP diaries.Efficacy Results in ED Patients with Diabetes Mellitus - Tadalafil tablets were shown to be effective in treating ED in patients with diabetes mellitus. Patients with diabetes were included in all 7 primary efficacy studies in the general ED population (N=235) and in one study that specifically assessed tadalafil tablets in ED patients with type 1 or type 2 diabetes (N=216). In this randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial, tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 15).Table 15: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in ED Patients with DiabetesEfficacy Results in ED Patients following Radical Prostatectomy - Tadalafil tablets were shown to be effective in treating patients who developed ED following bilateral nerve-sparing radical prostatectomy. In 1 randomized, placebo-controlled, double-blinded, parallel-arm design prospective trial in this population (N=303), tadalafil tablets demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 16).Table 16: Mean Endpoint and Change from Baseline for the Primary Efficacy Variables in a Study in Patients who Developed ED Following Bilateral Nerve-Sparing Radical ProstatectomyResults in Studies to Determine the Optimal Use of Tadalafil Tablets- Several studies were conducted with the objective of determining the optimal use of tadalafil tablets in the treatment of ED. In one of these studies, the percentage of patients reporting successful erections within 30 minutes of dosing was determined.

Ingredient	Amount per Dose	Purpose	Notes
Tadalafil	20 mg	Active ingredient, vasodilator	Main component for ED
Microcrystalline Cellulose	-	Filler	Binds ingredients
Magnesium Stearate	-	Excipient	Improves pill stability
Titanium Dioxide	-	Coloring agent	Provides yellow color